Akamai Technologies (AKAM) - FREE Research Report

Sagan Paul who is Director at AKAMAI TECH bought 180,669 shares at $14.33 per share for a total value of $1,433,250.00 on July 5, 2013. Following this transaction, the Director owned 847,233 shares meaning that the stake was boosted by 25.21% with the 180,669 share acquisition.

Historical insider transactions for Akamai Technologies go as follows:

  • 4-Week # shares sold: 592
  • 12-Week # shares sold: 10,592
  • 24-Week # shares sold: 10,592

The average volume for Akamai Technologies has been 2.7 million shares per day over the past 30 days. Akamai Technologies has a market cap of $7.6 billion and is part of the technology sector and internet industry. Shares are up 5.18% year to date as of the close of trading on Friday.

Akamai Technologies, Inc. provides content delivery and cloud infrastructure services for accelerating and improving the delivery of content and applications over the Internet in the United States and internationally. The company has a P/E ratio of 33.6. Currently there are 14 analysts that rate Akamai Technologies a buy, no analysts rate it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on AKAM - FREE

TheStreet Quant Ratings rates Akamai Technologies as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income, robust revenue growth and largely solid financial position with reasonable debt levels by most measures. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Akamai Technologies Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

Bet on Animal Health By Investing in Idexx Laboratories, Analysts Say

Cepheid (CPHD) Stock Downgraded to 'Neutral' at Baird

Cepheid (CPHD) Stock Price Target Raised at Barclays on Danaher Deal

Abbott's Alere Pushback Could Color Future Dealmaking Efforts

Jim Cramer's 'Mad Money' Recap: These Stocks Will Rise, Whatever the Fed Does